Literature DB >> 20122991

Organoselenium improves memory decline in mice: involvement of acetylcholinesterase activity.

Simone Pinton1, Juliana Trevisan da Rocha, Gilson Zeni, Cristina Wayne Nogueira.   

Abstract

The present study was designed to investigate the possible neuroprotective effect of p,p'-methoxyl-diphenyl diselenide [(MeOPhSe)(2)] in a model of sporadic dementia of Alzheimer's type (SDAT) induced by intracerebroventricular (i.c.v.) injection of streptozotocin (STZ) in mice. Mice were divided into four groups: (I) control, (II) (MeOPhSe)(2), (III) STZ, and (IV) (MeOPhSe)(2)+STZ. Mice were exposed to (MeOPhSe)(2) (25mg/kg, by gavage) and STZ (2mul of 2.5mg/ml solution; i.c.v.) or vehicles. 48 after that the exposure was repeated. Learning and memory were assessed with the step-down-type passive-avoidance (SDPA) and Morris water-maze (MWM) tests at the days 5-6 and 6-9, respectively. At the end of the experimental protocol animals were euthanized and cerebral cortex was removed for acetylcholinesterase (AChE) activity assay. Our results confirmed that i.c.v. STZ caused learning and memory deficits in mice, which were verified using the MWM and SDPA tasks. Furthermore, this study showed that AChE activity was increased in mice that received i.c.v. STZ. The most important findings of the present study are that (MeOPhSe)(2) was able to reverse the learning and memory impairments induced by STZ, and to protect against the increase in AChE activity. All these findings support the neuroprotective role of (MeOPhSe)(2) in a mice model of SDAT induced by i.c.v. STZ. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20122991     DOI: 10.1016/j.neulet.2010.01.057

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Organosulfur compound protects against memory decline induced by scopolamine through modulation of oxidative stress and Na+/K+ ATPase activity in mice.

Authors:  Fernanda D da Silva; Mikaela P Pinz; Renata L de Oliveira; Karline C Rodrigues; Francine R Ianiski; Mariana M Bassaco; Claudio C Silveira; Cristiano R Jesse; Silvane S Roman; Ethel A Wilhelm; Cristiane Luchese
Journal:  Metab Brain Dis       Date:  2017-07-14       Impact factor: 3.584

2.  Selenium compounds prevent amyloid β-peptide neurotoxicity in rat primary hippocampal neurons.

Authors:  Gabriela Lorea Godoi; Lisiane de Oliveira Porciúncula; Janaína Fagundes Schulz; Fernanda Neutzling Kaufmann; João Batista da Rocha; Diogo Onofre Gomes de Souza; Gabriele Ghisleni; Hiram Larangeira de Almeida
Journal:  Neurochem Res       Date:  2013-09-08       Impact factor: 3.996

3.  Design, Synthesis, and In Vitro Evaluation of a Novel Probucol Derivative: Protective Activity in Neuronal Cells Through GPx Upregulation.

Authors:  Ruth Liliám Quispe; Rômulo Faria Santos Canto; Michael Lorenz Jaramillo; Flavio Augusto Rocha Barbosa; Antônio Luiz Braga; Andreza Fabro de Bem; Marcelo Farina
Journal:  Mol Neurobiol       Date:  2018-02-12       Impact factor: 5.590

4.  2,2'-dipyridyl diselenide is a better antioxidant than other disubstituted diaryl diselenides.

Authors:  Cristiane Luchese; Ricardo Brandão; Carmine I Acker; Cristina W Nogueira
Journal:  Mol Cell Biochem       Date:  2012-04-29       Impact factor: 3.396

5.  Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.

Authors:  Rachel H L H Rueli; Daniel J Torres; Andrea S T Dewing; Arlene C Kiyohara; Stephanie M Barayuga; Miyoko T Bellinger; Jane H Uyehara-Lock; Lon R White; Paula I Moreira; Marla J Berry; George Perry; Frederick P Bellinger
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Hypervalent organochalcogenanes as inhibitors of protein tyrosine phosphatases.

Authors:  Leandro Piovan; Li Wu; Zhong-Yin Zhang; Leandro H Andrade
Journal:  Org Biomol Chem       Date:  2011-01-14       Impact factor: 3.876

7.  Structure-activity relationships of sulfonamides derived from carvacrol and their potential for the treatment of Alzheimer's disease.

Authors:  Márcia Maria de Souza; Marina Corrêa Andreolla; Thaís Cecília Ribeiro; Ana Elisa Gonçalves; Alex Rogério Medeiros; Anacleto Silva de Souza; Leonardo Luiz Gomes Ferreira; Adriano Defini Andricopulo; Rosendo Augusto Yunes; Aldo Sena de Oliveira
Journal:  RSC Med Chem       Date:  2020-02-14

8.  Intracerebroventricular Streptozotocin as a Model of Alzheimer's Disease: Neurochemical and Behavioral Characterization in Mice.

Authors:  Katherine Garcia Ravelli; Barbara Dos Anjos Rosário; Rosana Camarini; Marina Sorrentino Hernandes; Luiz Roberto Britto
Journal:  Neurotox Res       Date:  2016-12-02       Impact factor: 3.911

Review 9.  What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research.

Authors:  Melita Salkovic-Petrisic; Ana Knezovic; Siegfried Hoyer; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2012-08-12       Impact factor: 3.575

Review 10.  Toxicology and pharmacology of synthetic organoselenium compounds: an update.

Authors:  Cristina W Nogueira; Nilda V Barbosa; João B T Rocha
Journal:  Arch Toxicol       Date:  2021-04-01       Impact factor: 6.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.